Skip to content

Sotera Health SHC Treasury Stock, Value

Treasury Stock, Value at other companies

Cardinal Health logo
Cardinal HealthCAH
$7.22B+13.1%

Other financials

Income statement

See full
Revenue$280.0M+10.0%
Gross profit$147.1M+8.6%
Operating income$87.1M-16.2%
Net income$26.6M+301%
EPS (diluted)$0.09+280%

Balance sheet

See full
Cash & equivalents$314.1M+3.2%
Total debt$2.3B-3.2%
Total equity$622.5M+50.3%
Total assets$3.2B+4.5%

Cash flow

See full
Operating cash flow$29.4M-47.0%
CapEx$46.2M+132%
Free cash flow-$16.7M-147%

Valuation

See full
Market cap$4.51B+23.4%

Profitability

See full
Gross margin55.3%+0.1pp
Operating margin27%+0.7pp
Net margin9.9%+7.7pp
FCF margin8.1%

Returns & leverage

See full
Return on equity22.7%+16.8pp
Debt / equity3.6×-2.0×
Current ratio2.8×+0.4×

Where this comes from

Reported directly by Sotera Health in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockValue.

The official record: Sotera Health’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sotera Health's treasury stock, value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sotera Health's treasury stock, value?
Sotera Health (SHC) reported treasury stock, value of $12.1M in Q1 2026.
How has Sotera Health's treasury stock, value changed year-over-year?
Sotera Health's treasury stock, value decreased by 42.0% year-over-year, from $20.86M to $12.1M.
What is the long-term trend for Sotera Health's treasury stock, value?
Over 5 years (2020 to 2025), Sotera Health's treasury stock, value has grown at a -12.9% compound annual growth rate (CAGR), from $34M to $17.01M.
What does treasury stock, value mean?
This represents the cost of common shares that the company has repurchased from the open market and holds in its treasury. Treasury stock reduces total shareholders' equity and is often used for employee stock compensation plans or to return capital to shareholders. It is recorded as a contra-equity account.